Skip to Content

Posts tagged with "Business and Markets"

  • Business and Markets

    Muddying the Water For Fun and Profit

    I’ve been meaning to comment on some recent reports in the Wall Street Journal about the lengths that stock analysts have gone to get information on clinical trials. The main example was one David Risk of Sterling Financial (primarily a short-selling outfit, and quite sceptical of official company information.) Back in February, he signed on… Read More
  • Business and Markets

    Back For Some More

    Well, I’m back from a few days vacation with the kids. If there was any major science story breaking in the news, I sure didn’t hear about it. Not that I could hear very much over the background level of my 2- and (almost) 4-year-olds, mind you. Tomorrow, I can already tell, will be one… Read More
  • Business and Markets

    Marketing Ueber Alles

    The Wall St. Journal’s “Heard on the Street” column today made the case that Pfizer’s expansion isn’t really about scientific research. It’s about marketing. They’ll have a monstrously huge sales force, a big advertising budget, and so on. The article makes many of the same points that I’ve been harpi… Read More
  • Business and Markets

    By Any Other Name

    Is it just me, or does it seem a little odd that there was no doubt about what the Pfizer-Pharmacia merged company would be called? Recall that Sandoz and Ciba-Geigy threw two well-established brand names out the window to become Novartis. And Aventis had no choice when it formed; it was such a mouthful that… Read More
  • Business and Markets

    The Apatosaurus. The Spruce Goose. The Pyramids

    The news this morning is full of the Pfizer/Pharmacia (aka Pharmacia-Upjohn) merger. Perhaps this will trigger the long-expected wave of further drug company consolidation (but, then again, the Pfizer/Warner-Lambert deal was supposed to do that, too.) I hope it doesn’t, but I have to admit that the industry is congealing, and has been for som… Read More
  • Business and Markets

  • Business and Markets

    A Less-Than-Subtle Plan

    It seems that someone got very lucky just before the bad news hit at BMS (see the April 4 posting below.) That’s one explanation, and I hope that whoever it was is ready to defend it. Today’s Wall St. Journal reports that the day before the profit warning, some serious option transactions took place in… Read More
...102103104